Kawasumi has two business segments; "Blood Transfusion and Endovascular" and "Hemodialysis and Plasmapheresis" Blood Transfusion and Endovascular Hemodialysis and Plasmapheresis <Blood Banking and Transfusion> Blood-related medical devices such as Blood Bags, Blood Collection Device, and Apheresis Kits are used for blood collection, production and preserve of blood products. Kawasumi provides these devices to support the demand of safe blood. <Endovascular Repair> Kawasumi develops minimally invasive and highly-functional products such as Catheters and Stent Graft which are used for Endovascular...

Consolidated Financial Highlights- (HSR/¥ Million) ■ USS-mirtWa / Blood Transfusion and Endovascular Operating Income (HSR/¥ Million) i^f-USS / Operating income i^f-USS^ / Operating income to net sales : Total Assets l^7U — •^FVy^J.'yn— Free Cash Flow Free cash flow = Cash flow from operating activities + Cash flow from investing activities

Financial Data- IROA Return on Assets I ROE Return on Equity I ElSft^0$E^ Equity Turnover I §2St^tfc^ Equity Ratio I JmUjtfc^ Current Ratio I HDAE!!:!^ Fixed Ratio ;±: ROA = SS« + e«S («*¥)*)) X100 gS«*B$i* = 5E±?B + Se«*«S*¥eB Sffl&tt* = SfflMtS + »@fll x 100 ROE = SlWtfflffi + g3«*(ISS*¥E)) x 100 gS«*hW = miM + WlM x 100 BStt* = BSHS ^-x 100

Capital Expenditures (HSR/¥ Million) (HSR/¥ Million) 11 ^r^mmmm Net income per Share 11 ^fc^TcUMSIS Net Assets per Share 11 ^^TcUIS^^^F^) Annual Cash Dividends per Share Notes: ROA = Ordinary income / Total assets(yearly average) x 100 Equity turnover = Net sales / Equity capital(yearly averag ROE = Net income / Equity capital(yearly average) x 100 Equity ratio = Net assets / Total assets x 100 Current ratio = Current assets / Current liabilities x 100 Fixed ratio = Fixed assets / Equity capital x 100

Consolidated Financial Statements I J^lnlJfEi^tP,Ri^ Consolidated Balance Sheets (SBP3 /¥ Million)

Consolidated Statements of Cash Flows ^^SBjIi-^'S+l'iyi^n.'^n- Cash flow from operating activities:

Investor Information — Company Data Company name Kawasumi Laboratories, Incorporated ^±Wi§P/f Head office Shinagawa Intercity Tower B, 9th Floor 2-15-2, Konan, Minato-ku Yoshio Sakaya President and Chief Executive Officer Paid-in capital Fiscal year-end Securities code Main businesses Manufacturing and sales of medical devices and pharmaceuticals Kawasumi Laboratories (Thailand) Co., Ltd. Kawasumi Laboratories America, Inc. Kawasumi Platech Incorporated ■ ^lC(D^?5E (2015^3^31 BfflE) Share Information (As of March 31, 2015) ^T°Til§$r:iC§§iS Authorized number of shares PlfTjn^lC©l8U(ge«i3£SC) Total...